MATTHEW SIRO, MBA

Sparks, NV 775-***-**** ad0ncs@r.postjobfree.com www.linkedin.com/in/matthew-william-siro-mba

PHARMACEUTICAL SALES SPECIALIST, PRIMARY CARE Oncology

Strategic Sales Planning Healthcare & Medical Relationship Building

Summary of Qualifications

●Top-producing, results-oriented pharmaceutical sales specialist with 12 years of experience developing and implementing cost-effective sales strategies that deliver record-setting revenue growth and profit enhancement.

●Effective sales strategist with proven expertise in exceeding sales targets, increasing leads, capturing market share, and maximizing client base. Strong background in marketing operations, training, and facilitation.

●Collaborative, trusted partner who specializes in building and cultivating rewarding relationships with colleagues, clients, and senior leaders across multiple industries.

Areas of Expertise

Organizational: Revenue Growth & Profitability Product Knowledge Product Implementation Sales Account Management Customer Relations Marketing Campaigns & Promotions Leadership Training & Facilitation MS Office Suite

Languages: English Belgian Flemish

Professional Experience

NOVARTIS PHARMACEUTICALS CORPORATION East Hanover, NJ September 1997 – July 2011

ONCOLOGY SALES SPECIALIST 1998–2001 and 2003–2011

Led sales training and development in New York and Connecticut for five medication launches, including Zometa, Gleevec, Sandostatin (SDS) LAR Depot, Aredia, and Femara. Served as Chair and Co-Chair of Diversity Committee, and Sales Advisory Committee.

●Designed curriculum guidelines for oncology reimbursement related to Zometa launch; coached and mentored 2K+ internal oncology representatives to utilize guide as sales aid and billing assistance

●Drove revenue enhancement through launch and promotion of medications to oncologists, hematologists, urologists, endocrinologists, and GI physicians

●Expanded business and increased profitability by generating Femara market share from 5% to 55%; Aredia and Zometa sales met 117% of goal; and SDS LAR met 147% of goal, with total rank of 7/225

●Increased sales leads through territory expansion from 10% market share to 80% for Zometa

●Earned three MVP National Sales Awards in 1998, 2001, and 2005 and several commendations for outstanding performance and achievements in Northeast territory

MANAGER, ONCOLOGY CUSTOMER MARKETING (Rotational Role) 2001–2003

Aligned marketing- and oncology-managed markets and oversaw $5M budget.

●Created and implemented Oncology Hotline and Patient Assistance program for four brands, including SDS LAR, Gleevec, Zometa, and Femara in partnership with Documedics and Express Scripts to drive sales initiatives

●Created website dedicated to reimbursement guidelines and practical information for Gleevec and Zometa; trained sales representatives to utilize website and share knowledge with clients

●Identified and executed purchasing strategies across sales, marketing and scientific operations for corporate customers, including ION, NOA, U.S. Oncology, and target outlets such as Kaiser by developing account team management platform

●Developed and launched Femara program: series of video vignettes entitled “Healing Conversation” intended for cancer physician education of patient experiences with diagnosis, treatment, and level of care

●Facilitated new hire training for oncology reimbursement, Medicare, Medicaid and private insurance companies

●Planned and executed three annual National Consultant meetings comprised of 240 key opinion leaders; managed $5M event budget; provided vendor management and secured physicians across three districts to participate

●Designed reimbursement tools for sales force by coordinating with brand teams and advertising agencies

●Reviewed and processed reimbursement for products with Centers for Medicare and Medicaid Services (CMS), including launch of Zometa in bone metastasis; administered reimbursement guides for Zometa and Gleevec

●Performed market research for product line during consultant meetings and web-based advisory meetings

Additional Experience

Sales Consultant Novartis Pharmaceuticals Corporation, East Hanover, NJ 1997 – 1998

Promoted as result of selling Lescol, Lotensin, and Lamisil to 200 primary care doctors in Brooklyn in one year, resulting in Lamisil market share increase from 42.6% to 84%; and Lescol from 23.7% to 96%. Acquired business against major competitors, resulting in Top 2% ranking of 55 in regional sales and second for President’s Club.

Continuing Education

Oncology/Hematology Course Completion MD Anderson Cancer Center Received: 2002

Education

Master of Business Administration, Global Business

Fairleigh Dickinson University Teaneck, NJ

Bachelor of Science, Business Administration

Centenary College Hackettstown, NJ

Contact this candidate